droxinavir
{{chembox
| Verifiedfields = changed
| verifiedrevid =
| ImageFile = Droxinavir structure.svg
| ImageSize = 220px
| IUPACName = 3-tert-butyl-1-[(2R,3S)-3-[(2S)-3,3-dimethyl-2-[2-(methylamino)acetamido]butyramido]-2-hydroxy-4-phenylbutyl-1-isopentylurea
| OtherNames = SC 55389A
|Section1 = {{Chembox Identifiers
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 409165
| InChI =
| InChIKey =
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C29H51N5O4/c1-19(2)15-22(26(37)34-29(6,7)8)31-17-23(35)21(16-20-13-11-10-12-14-20)32-27(38)25(28(3,4)5)33-24(36)18-30-9/h10-14,19,21-23,25,30-31,35H,15-18H2,1-9H3,(H,32,38)(H,33,36)(H,34,37)/t21-,22?,23+,25+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PLQLXAKSONXQOQ-XCZUPJPTSA-N
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3CF21QCB9J
| CASNo_Ref = {{cascite|correct|??}}
| CASNo = 159910-86-8
| PubChem = 70683043
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2110878
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG =
| SMILES = CC(C)CC(C(=O)NC(C)(C)C)NCC(C(CC1=CC=CC=C1)NC(=O)C(C(C)(C)C)NC(=O)CNC)O
}}
|Section2 = {{Chembox Properties
| Formula = C29H51N5O4
| MolarMass = 533.75 g·mol−1
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
| Solubility =
}}
|Section3 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
}}
}}
Droxinavir (also known as SC 55389A) was an experimental protease inhibitor researched by Pharmacia as a treatment for HIV infection. Its research and development was discontinued on March 06, 1995.{{cite web|title=Drug Profile: Droxinavir|url=http://adisinsight.springer.com/drugs/800004768|website=AdisInsight|publisher=Adis International Ltd, part of Springer Science+Business Media|access-date=23 November 2015}}